Investment archive

Investment feed — page 17

Back to latest investments

Sanyou Bio announces Series C of under approximately $15M, funded by Zero2IPO Industry Investment

Sanyou Bio announces Series C of under approximately $15M, funded by Zero2IPO Industry Investment

November 9, 2026 issuer announcement: Sanyou Bio completed an amount-qualified Series C exclusively financed by Zero2IPO Industry Investment, managed by Zero2IPO Group. At the November 9 ECB rates, the reported ceiling converts to less than approximately $15M; the exact round sum and legal close date are not disclosed. Company-reported cumulative financing below about $45M is NOT new Series C proceeds.

geniosAI discloses $19.1M combined seed and Series A, with FactSet leading Series A

geniosAI discloses $19.1M combined seed and Series A, with FactSet leading Series A

On Nov 9 2026 geniosAI disclosed $19.1M in combined prior seed and Series A financing. FactSet led Series A, with Zoom and General Catalyst among investors. Individual tranches, dates, valuation and amount NEWLY closed Nov 9 are undisclosed. Record $19.1M once as combined disclosed capital, not a $19.1M standalone Series A.

SRTD Biotech completes €31.5M seed for cell-selective RNA therapeutics

SRTD Biotech completes €31.5M seed for cell-selective RNA therapeutics

Jülich-based SRTD Biotech announced the completed €31.5M seed Nov 9, 2026, led by Mérieux Equity Partners with NRW.BANK and Boehringer Ingelheim Venture Fund co-leading, plus Lilly Ventures, HTGF and Anobis. NRW.BANK disclosed €7M included in the round. Funds preclinical seRNA studies toward IND; valuation undisclosed.

Spines secures separate $35M non-dilutive financing facility from Twelve

Spines secures separate $35M non-dilutive financing facility from Twelve

November 9, 2026 issuer announcement: Twelve provides a $35M non-dilutive growth financing facility to Spines, separate from a $29M Series A-1 equity round. Facility drawdown, pricing, repayment, collateral and conditions are undisclosed; capacity is not necessarily cash received.

Spines announces $29M Series A-1 equity led by Zeev Ventures within mixed $64M package

Spines announces $29M Series A-1 equity led by Zeev Ventures within mixed $64M package

Spines' November 9 company-issued release separates $29M Series A-1 equity led by Zeev Ventures from a separate $35M non-dilutive growth-financing facility provided by Twelve. The $64M total is mixed financing, not a $64M equity round. Valuation and legal completion date not disclosed.

Project Omega announces $80M Series A led by B Capital to develop nuclear recycling and radioisotope power

Project Omega announces $80M Series A led by B Capital to develop nuclear recycling and radioisotope power

On November 9, 2026, Project Omega announced an $80M Series A led by B Capital, with noa VC, 645 Ventures and returning investors participating. The funding supports planned fuel-recycling pilot infrastructure and power-system development, not an already operating commercial refinery. Valuation and legal close date undisclosed.

Coframe announces $25M Series A co-led by Khosla Ventures and Hanabi Capital

Coframe announces $25M Series A co-led by Khosla Ventures and Hanabi Capital

Coframe Inc.'s own November 9, 2026 PR Newswire release confirms a $25M Series A co-led by Khosla Ventures and Hanabi Capital, within $35M company-reported lifetime funding. The earlier $9.3M seed was announced October 2024 and remains separate. The $0.7M difference between individually identified rounds and the lifetime tally is unresolved; valuation and exact legal closing date undisclosed.

Marble Imaging adds €6M in second seed close led by Cherry Ventures

Marble Imaging adds €6M in second seed close led by Cherry Ventures

On Nov 9, 2026 Cherry Ventures confirmed leading an additional €6M second close of Marble Imaging's seed. It follows a separate €5.3M first close announced Dec 1, 2025, bringing the cumulative seed to €11.3M. Neither the older first close nor non-dilutive ESA/DLR support is newly raised in Nov 2026. Legal completion date separately from announcement unconfirmed.

Onodrim Industries raises $300M Series A at company-stated $1.3B valuation

Onodrim Industries raises $300M Series A at company-stated $1.3B valuation

On November 9, 2026, Amsterdam-based Onodrim Industries announced a $300M Series A led by Lux Capital with General Catalyst, Lakestar, Altimeter, Strike Capital, 137 Ventures, 8090 and Expeditions participating. The stated $1.3B company valuation is not specified as pre- or post-money. Capital is intended for future controlling-stake industrial acquisitions; no first acquisitions were named.

Vudoo closes approximately $15.1M Series B, led by Blue Sky Capital (USD converted)

Vudoo closes approximately $15.1M Series B, led by Blue Sky Capital (USD converted)

Melbourne commerce-media company Vudoo announced on November 9, 2026 that it had closed a Series B equivalent to approximately $15.1 million USD at the ECB's November 6 FX fixing, led by Blue Sky Capital with unnamed existing family-office investors. Several secondary headlines omit the original currency denomination, overstating the amount if read as USD. Valuation and all-time funding undisclosed.

Physicl announces $10M seed led by Inovia Capital for physical-AI training data

Physicl announces $10M seed led by Inovia Capital for physical-AI training data

On November 6, 2026, Physicl announced a $10 million seed led by Inovia Capital with U.S. Venture Partners participating. The company launched a private beta of Studio for synthetic physical-AI training data. Valuation and legal closing date were not disclosed; Insight Partners is described as a backer but not confirmed in this seed.

Synctera announces $24.5M new financing; $126.7M lifetime funding

Synctera announces $24.5M new financing; $126.7M lifetime funding

Synctera announced $24.5M of new funding on November 6, 2026, with Multiplier Capital, Fin Capital, 1st & Main Growth Partners, Diagram and NAventures participating. The issuer did not identify an equity round stage, instrument, valuation or lead. The company's $126.7M lifetime reported capital is cumulative, not new proceeds. It separately reported eight active sponsor banks, 20 newly signed clients in 2026, and first Synctera Labs launches planned for February 2027.